Epilepsy in the adolescent.
D000086:Acetazolamide / Q000627:therapeutic use; D000293:Adolescent; D000367:Age Factors; D000435:Alcoholic Intoxication / Q000150:complications; D000661:Amphetamine / Q000009:adverse effects; D000927:Anticonvulsants / Q000008:administration & dosage / Q000627:therapeutic use; D001294:Attitude to Health; D002220:Carbamazepine / Q000627:therapeutic use; D002540:Cerebral Cortex / Q000503:physiopathology; D003276:Contraceptives, Oral / Q000009:adverse effects; D004347:Drug Interactions; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects; D008297:Male; D010634:Phenobarbital / Q000008:administration & dosage / Q000627:therapeutic use; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use; D011584:Psychology; D011627:Puberty; D019966:Substance-Related Disorders / Q000150:complications
D000927:Anticonvulsants; D003276:Contraceptives, Oral; D002220:Carbamazepine; D010672:Phenytoin; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D000086:Acetazolamide; D010634:Phenobarbital